Contract 36C25024N0314
Binding Site, Inc., The · Department Of Veterans Affairs · February 2, 2024
Binding Site, Inc., The was awarded a federal contract by Department Of Veterans Affairs on February 2, 2024 for $138,000 of work in biological product (except diagnostic) manufacturing. Performance is in San Diego, CA. This is a task or delivery order issued under parent IDIQ 36C25022D0034. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 18, 2026. If all options are exercised, the contract could reach $786,000.
Contract details
- PIID
- 36C25024N0314
- Parent IDIQ
- 36C25022D0034
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Not Competed
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- Place of performance
- San Diego, CA
- First action
- February 2, 2024
- Latest action
- March 18, 2026
Description
FUNDS NOT NEEDED -$34,532.19 OPTILITE REAGENT EXERCISING OY2 TO CORRECT UNIT PRICES FOR OY2
Modification timeline
-
March 18, 2026Mod P00002$-34.5K
-
September 26, 2024Mod P00001OPTILITE REAGENT EXERCISING OY2 TO CORRECT UNIT PRICES FOR OY2$5.1K
-
February 2, 2024Base awardOPTILITE REAGENT EXERCISING OY2$167.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| American National Red Cross, The | Department Of Veterans Affairs | March 25, 2026 | $1.65M |
| New York Blood Center, Inc. | Department Of Veterans Affairs | March 18, 2026 | $670.0K |
| Binding Site, Inc., The | Department Of Veterans Affairs | March 18, 2026 | $102.8K |
| Binding Site, Inc., The | Department Of Veterans Affairs | March 18, 2026 | $124.6K |
| Binding Site, Inc., The | Department Of Veterans Affairs | March 18, 2026 | $0 |
| Mississippi Blood Services, Inc. | Department Of Veterans Affairs | March 11, 2026 | $451.2K |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C25024N0314?
Contract 36C25024N0314 is a federal contract awarded to Binding Site, Inc., The by Department Of Veterans Affairs on February 2, 2024 for $138,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36C25024N0314?
Binding Site, Inc., The won contract 36C25024N0314 from Department Of Veterans Affairs.
How much is contract 36C25024N0314 worth?
Contract 36C25024N0314 has obligated $138,000 to date, with a total potential value of $786,000 if all options are exercised.